Home/Pipeline/CORTONE (cortisone)

CORTONE (cortisone)

Rheumatoid Arthritis

CommercialActive

Key Facts

Indication

Rheumatoid Arthritis

Phase

Commercial

Status

Active

Company

Merck

About Merck

Merck & Co., Inc. is a leading research-intensive biopharmaceutical company founded in 1891 and headquartered in Rahway, New Jersey. With a market valuation of approximately $282 billion, the company has built a legacy of breakthrough medicines and vaccines, including the blockbuster cancer immunotherapy Keytruda and vaccines like Gardasil. Merck operates globally, reaching 92% of the world's countries with its products and serving over 450 million people with medicines and vaccines in 2024.

View full company profile

Therapeutic Areas

Oncology Vaccines Animal Health Infectious Diseases Cardiovascular Disease Diabetes HIV/AIDS

Other Rheumatoid Arthritis Drugs

Drug	Company	Phase	Status
Early Detection Test for Rheumatoid Arthritis	Age Labs	Development	Active
Kevzara (sarilumab)	Regeneron Pharmaceuticals	Approved	Commercial
Actemra (tocilizumab)	Chugai Pharmaceutical	Approved	Commercial
Tocilizumab	Biocon	Filed	Regulatory Review
Humira	Abbott India	Approved	Commercial
KPL-404	Kiniksa Pharmaceuticals	Phase 2	In Development
Tibulizumab (ZB-106)	Zura Bio	Phase 1b	Completed
Zunsemetinib (ATI-450)	Aclaris Therapeutics	Phase 2b	Active
Natrunix Program	XBiotech	Not Specified	Active
LEAPS Technology	CEL-SCI	Pre-clinical	Early Development
Piclidenoson (CF101)	Can Fite Biopharma	Phase 3	Active/Completed
Targeted Immunotherapy for Rheumatoid Arthritis (via Arthritis4Cure)	LFB	Pre-clinical	Development (Partnership)